This page synthesizes findings across 1,426 source pages to map the relationships between metals and disease. Where individual source pages document a single study's findings, this page identifies the patterns that emerge when those findings are laid side by side.
ADVERSARIAL CAVEAT: This matrix synthesizes findings from 1,426 source pages. Most evidence is observational or mechanistic. Prospective validation is ongoing for most metallomic associations.
Readers should treat the patterns described here as hypothesis-generating rather than clinically established. The distance between a statistically significant association in a cross-sectional study and a validated diagnostic or therapeutic target is substantial.
Evidence map63 cited passagesInspect provenance +
copper elevation in biofluids is the single most consistent finding across the disease landscape. The comprehensive cancer metallomics review found Cu "almost universally increased across cancer types in blood/serum/plasma." This pattern extends beyond cancer:
PCOS: Meta-analysis of 9 studies (n=2,274) confirmed significantly higher serum Cu (SMD 0.51, p < 0.0001), replicated in a large n=766 cohort
AMI/CVD: Cu significantly elevated at 0.85 vs. 0.73 ug/mL (p < 0.01), remaining elevated 1 month post-intervention
Cancer: Elevated in breast, prostate, lung, colorectal, pancreatic (ATP7A overexpression), and thyroid cancer
PPD: Elevated serum Cu in women with postpartum depression history
The critical exception is the brain in neurodegeneration. found widespread Cu decreases across all three dementias (DLB, AD, PDD) in post-mortem brain tissue. This paradox—peripheral Cu excess with central Cu deficiency—suggests disturbed Cu trafficking rather than simple overload. Ceruloplasmin dysfunction may be the link: it both elevates circulating
The emerging concept of cuproptosis (Cu-dependent cell death via FDX1) adds a mechanistic layer, particularly in thyroid cancer.
T2D: Urinary Zn loss is a hallmark; ZnT8 transporter mutations associated with disease
Breast cancer: Significantly lower in plasma/serum (SMD -2.09)
Prostate cancer: 0.51 vs. 0.82 ug/mL in healthy controls
Colorectal cancer: European cohort of 58,221 confirmed significant association
Autism: The most consistent finding in ASD metal studies is decreased hair Zn
PPD: Serum Zn 2.5-fold lower in PPD cases; 100 mg/day supplementation OR 0.249 for PPD prevention
Depression: Severity inversely correlated with serum Zn; supplementation augments SSRI response
Dysmenorrhea: Zn supplementation produces large pain reductions (Hedges's g = -1.541)
Thyroid/Hashimoto's: 49.1% prevalence of Zn deficiency in hypothyroid patients (OR 5.926); Zn necessary for TRH, TSH, T3, T4 production (, )
Ulcerative colitis: Depleted, impairing mucosal healing and tight junction integrity
Crohn's disease: ZIP8 A391T variant alters Zn handling; Paneth cell defensins require Zn
The mechanism connecting Zn depletion to such diverse diseases centers on Zn's role in over 300 metalloenzymes, DNA stabilization, immune regulation, and particularly Cu/Zn-SOD antioxidant defense. Toxic metals (Pb, Cd, Hg) may worsen Zn status by competing for protein binding sites, effectively creating functional Zn deficiency even when total body Zn is ad
All major cancers (breast, prostate, lung, colorectal, thyroid, pancreatic)
PCOS
AMI/CVD
Thyroid autoimmunity
PPD
Showing 24 of 63 evidence-bearing passages. Every remaining citation is still indexed in the reference record below.
Contents
1. 1. Metal-Disease Matrix2. 2. Cross-Disease Metal Signatures3. 3. Mismetallation Across Diseases4. 4. Shared Mechanistic Pathways5. 5. The Nickel Hub6. 6. Diagnostic Potential: Metallomics as a Clinical Tool7. 7. Intervention Evidence8. 8. Convergence1. Metal-Disease Matrix#
The matrix below reports the predominant direction of association found across the source literature. Each cell reflects the weight of evidence from multiple studies where available. Arrows indicate whether metal levels are typically elevated or depleted in patients relative to healthy controls; mixed results or insufficient evidence are noted.
Legend: ↑ = elevated in disease, ↓ = depleted in disease, ↑↓ = dysregulated (evidence in both directions or context-dependent),—= no significant change or insufficient data, ? = not studied or data lacking.
1A. Original 12 Diseases (Updated)#
| Disease | [[nickel | nickel (Ni)]] | [[copper | copper (Cu)]] | [[zinc | zinc (Zn)]] | [[iron | iron (Fe)]] | [[selenium | selenium (Se)]] | [[manganese | manganese (Mn)]] | [[lead | lead (Pb)]] | [[cadmium | cadmium (Cd)]] | [[mercury | mercury (Hg)]] | [[arsenic | As]] | [[chromium | chromium (Cr)]] | [[aluminum | aluminum (Al)]] |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PCOS | ↑ (erythrocytes, obese) | ↑ (meta-analysis) | ↑↓ (conflicting) | ↑ | — | — | ↑ | ↑ | ↑ | ↑ | — | ? | ||||||||||||
| Breast cancer | ↑ (tissue) | ↑ (serum, tissue) | ↓ (serum, hair) | ↑↓ | ↓ | ↓ (serum) | ↑ | ↑ (metalloestrogen) | — | — | — | ? | ||||||||||||
| T2D | ↑ (urinary) | ↑↓ | ↓ (urinary loss) | ↑ (ferritin) | — | ↓ | ↑ | ↑ | — | ↑ | ↓ (deficiency) | ? | ||||||||||||
| Alzheimer's | ? | ↓ (brain) | ↑↓ (plaques ↑, serum ↓) | ↑ (brain accumulation) | ↓ | ↑↓ | ↑ (epigenetic) | ↑ | ↑ | ↑ | — | ↑ (brain) | ||||||||||||
| Parkinson's | — | ↓ (brain) | ↓ (serum) | ↑ (substantia nigra, ferroptosis) | ↓ | ↑ (basal ganglia) | ↑ | ↑ | ↑ | — | — | — | ||||||||||||
| Rheumatoid arthritis | ↓ | ↑↓ (conflicting) | — | — | — | — | ↑ | ↑ | — | ↑ (metabolites) | ↑ | — | ||||||||||||
| CKD | — | — | — | ↑↓ (ferroptosis) | — | — | ↑ (reduced excretion) | ↑ (nephrotoxic) | ↑ (nephrotoxic) | ↑ | ↑ | — | ||||||||||||
| Autism (ASD) | ? | ↑↓ | ↓ (hair, consistent) | — | — | — | ↑ (hair, blood) | ↑ (hair, urine) | ↑ (blood, hair) | — | — | — | ||||||||||||
| Lung cancer | ↑ (serum, 1.6-fold) | ↑ | ↑↓ | ↓ | ↑↓ | ↑↓ | ↑ | ↑ (smoking) | — | ↑↓ | ↑ (urine) | ↑ (2.35-fold) | ||||||||||||
| Prostate cancer | ↑ | ↑ | ↓ | ↑ | ↓ | — | — | ↑ | — | — | — | — | ||||||||||||
| AMI/CVD | ↑ (post-MI serum) | ↑ (persistent) | — | ↓ (acute) | ↓ (persistent) | — | — | (smoking confounder) | — | ↓ | — | — | ||||||||||||
| Thyroid disease (general) | ↑ (dose-response) | ↑ (copper/zinc ratio in cancer) | ↓ (deficiency impairs TH) | ↓ (58% HT anemic) | ↓ (deiodinase impairment) | ↑ (autoimmune hypothyroid) | ↑ (blocks deiodination) | ↑ (inhibits T4-T3) | ↑ (inhibits TPO) | — | — | — |
1B. Expanded Diseases (New Rows)#
| Disease | [[nickel | nickel (Ni)]] | [[copper | copper (Cu)]] | [[zinc | zinc (Zn)]] | [[iron | iron (Fe)]] | [[selenium | selenium (Se)]] | [[manganese | manganese (Mn)]] | [[lead | lead (Pb)]] | [[cadmium | cadmium (Cd)]] | [[mercury | mercury (Hg)]] | [[arsenic | As]] | [[chromium | chromium (Cr)]] | [[aluminum | aluminum (Al)]] |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Schizophrenia | ? | ↑ (serum, ceruloplasmin) | ↓ (serum; NMDA hypofunction) | ↑↓ (Fenton in dopaminergic circuits) | ? | ? | ? | ? | ? | ? | ? | ? | ||||||||||||
| Depression | ? | ↑ (serum, ceruloplasmin) | ↓ (consistent, severity-correlated) | ↑↓ (deficiency common; overload also risk) | ? | ? | ↑ (childhood exposure predicts adult MDD) | ↑ (NHANES association) | ↑ (occupational/dietary methylmercury) | ? | ? | ? | ||||||||||||
| GERD | ↑ (dietary trigger in nickel-allergic; 95% improve on low-nickel) | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? | ||||||||||||
| Ovarian cancer | ↑ (ERa binding, epigenetic) | ? | ? | ↑↓ (ferroptosis target) | ? | ? | ? | ↑ (metalloestrogen, ERa Kd 4.5e-10) | ? | ↑ (oxidative stress) | ? | ? | ||||||||||||
| Gastric cancer | ↑ (H. pylori metalloenzyme substrate) | ? | ? | ↑↓ (host sequestration vs luminal excess) | ? | ? | ↑ (occupational) | ↑ (IARC Group 1 for stomach) | ? | ? | ? | ? | ||||||||||||
| IBS | ↑ (30-65% nickel sensitization in IBS cohorts) | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? | ||||||||||||
| Ulcerative colitis | ? | ↑ (acute phase) | ↓ (barrier dysfunction) | ↓ (chronic mucosal bleeding; 60-80% iron-deficient) | ↓ (severity-correlated) | ? | ? | ? | ? | ? | ? | ? | ||||||||||||
| Crohn's disease | ? | ↑ (CRP-correlated) | ↓ (ZIP8 variant; barrier/Paneth cell) | ↑↓ (true deficiency + functional withholding) | ? | ? | ? | ↑ (ZIP8 A391T variant) | ? | ? | ? | ? | ||||||||||||
| T1D | ? | ? | ↓ (ZnT8 autoantigen; insulin hexamer) | ↑ (islet overload; Fenton chemistry) | ? | ? | ? | ? | ? | ? | ? | ? | ||||||||||||
| Hashimoto's | ↑ (dose-response thyroid dysfunction) | ↑ (copper/zinc ratio altered) | ↓ (49.1% deficient; OR 5.926) | ↓ (58% anemic; TPO impaired) | ↓ (critical: 200ug/day reduces anti-TPO 40%) | ? | ↑ (blocks deiodination) | ↑ (inhibits 5'-monodeiodinase) | ↑ (inhibits TPO, Tg iodination) | ? | ? | ? | ||||||||||||
| Graves' disease | ? | ? | ? | ↓ (common in AITD) | ↓ (ophthalmopathy risk; 200ug/day RCT benefit) | ? | ? | ↑ (selenium antagonism) | ↑ (selenium antagonism) | ? | ? | ? | ||||||||||||
| Pancreatic cancer | ? | ↑ (urine, serum; ATP7A overexpression) | ↑↓ (urine ↑, tissue ↓; isotope fractionation) | ? | ↓ | ? | ? | ↑ (tissue) | ? | ? | ? | ? | ||||||||||||
| Hypertension | ? | ? | ? | ? | ? | ? | ↑ (eNOS inhibition, RAAS activation; even <10ug/dL) | ↑ (renal tubular damage; BP dysregulation) | ? | ? | ? | ? | ||||||||||||
| Obesity | ↑ (59.7% nickel-allergic in overweight women; NAFLD mediator) | ? | ? | ↑ (fecal; metal-microbiome pathway) | ? | ↑ (fecal) | ? | ↑ (fecal; inversely correlates with Bifidobacteriaceae) | ? | ? | ? | ? | ||||||||||||
| Colorectal cancer | ↑ (inconsistent) | ↑ (copper/zinc ratio first proposed as CRC marker) | ↓ (n=58,221 European cohort) | ↑ (heme iron; N-nitroso compounds) | ↓ | ? | ? | ↑ (IARC Group 1) | ? | ↑ (IARC Group 1) | ↑ (chromium VI; VEGFA, EGFR hub genes) | ? | ||||||||||||
| Endometriosis | ↑ (peritoneal 40.4 ug/L vs <LOD; 90.3% nickel ACM) | ↑ (microbial virulence cofactor) | ↑ (local; MMP cofactor) | ↑ (peritoneal; retrograde menstruation) | ? | ? | ↑ (75 vs 0.72 ug/L peritoneal) | ↑ (metalloestrogen) | ? | ? | ? | ? | ||||||||||||
| Multiple sclerosis | ? | ? (ceruloplasmin role indirect) | ? (oligodendrocyte myelin role) | ↑ (deep gray matter; progressive MS) | ? | ? | ? | ? | ? | ? | ? | ? | ||||||||||||
| PPD | ? | ↑ (serum) | ↓ (2.5-fold lower; 100mg/day OR 0.249) | ↓ (ferritin <1ug = 3.98x risk) | ? | ? | ↑ (weak; OR 1.19 per doubling) | ? | ? | ? | ? | ? |
Reading the Matrix#
Several patterns emerge from the expanded 28-disease landscape.
Copper elevation appears in the majority of disease rows—cancers (breast, prostate, lung, colorectal, pancreatic), PCOS, AMI, thyroid cancer, schizophrenia, depression, PPD, ulcerative colitis, Crohn's, and endometriosis. The exceptions are neurodegenerative diseases, where brain copper (Cu) is depleted even as peripheral copper may be normal or elevated.
This peripheral-central dissociation reflects disturbed copper trafficking rather than simple overload.
Zinc depletion is the mirror image of copper elevation, now documented across breast cancer, T2D, prostate cancer, autism, thyroid disease, depression, schizophrenia, T1D, Hashimoto's, ulcerative colitis, Crohn's, PPD, and colorectal cancer. The copper/zinc (Zn) ratio captures both signals simultaneously and may be the single most reproducible metallomic biomarker.
Lead and cadmium are elevated in virtually every disease examined. These two toxic metals show no disease specificity—their harm is systemic.
The new rows reinforce this: lead (Pb) in hypertension (even at <10 ug/dL), cadmium (Cd) in gastric cancer (IARC Group 1), cadmium in obesity (fecal levels inversely correlated with protective bacteria).
Iron dysregulation remains the most context-dependent pattern. Iron accumulates in Parkinson's substantia nigra, Alzheimer's brain, T2D (ferritin), islet cells in T1D, and endometriosis peritoneal fluid. It is depleted in ulcerative colitis (chronic bleeding), Hashimoto's (58% anemic), PPD (ferritin <1 ug = 3.98x risk), and AMI (acute depletion).
Selenium depletion tracks with impaired antioxidant defense, with new emphasis on its critical role in thyroid autoimmunity (Hashimoto's and Graves') where it is both protective and therapeutic.
Nickel sensitivity is the most disease-specific finding in the matrix: refractory GERD (95% improve on low-nickel (Ni) diet), IBS (30-65% nickel sensitization), endometriosis (90.3% nickel ACM), and obesity (59.7% nickel-allergic in overweight women) represent a cluster of conditions where nickel allergy appears to be a major, underdiagnosed driver.
Key Caveats#
The matrix simplifies complex, sometimes contradictory evidence. Several important limitations apply:
- Biomarker matrix matters: Serum copper (Cu) elevation in cancer does not mean the same thing as brain copper depletion in Alzheimer's. Peritoneal fluid metals in endometriosis differ from serum levels. The compartment measured determines the direction observed.
- Conflicting studies exist: zinc (Zn) in PCOS is elevated in some studies and depleted in others. copper in RA is elevated in some cohorts and depleted in others. Iron in T1D shows both islet overload and systemic markers of stress.
- Confounding is pervasive: Smoking drives cadmium (Cd) levels; diet drives nickel (Ni) and lead (Pb); geography determines As and chromium (Cr) exposure. Many studies inadequately control for these factors.
- Cross-sectional designs dominate: Most studies cannot distinguish whether metal changes are causes, consequences, or bystanders of disease.
- Discovery-study bias (ADVERSARIAL): The expanded rows in Section 1B are drawn from fewer studies per cell than Section 1A. Many cells marked "?" reflect absence of study, not absence of association. The matrix should be read as a map of what has been studied, not a map of what exists.
2. Cross-Disease Metal Signatures#
Copper: The Nearly Universal Disease Marker#
Copper elevation in biofluids is the single most consistent finding across the disease landscape. The[1]Recent advances in the application of metallomics in diagnosis and prognosis of human cancerYan Zhang, Jie He, Jiao Jin et al. · 2022Open reference 1 ↓ comprehensive cancer metallomics review found copper (Cu) "almost universally increased across cancer types in blood/serum/plasma." This pattern extends beyond cancer.
PCOS: Meta-analysis of 9 studies (n=2,274) confirmed significantly higher serum copper (SMD 0.51, p < 0.0001),[2]Serum Copper Level and Polycystic Ovarian Syndrome: A Meta-AnalysisJiang Q, Zhang F, Han L et al. · 2021Open reference 2 ↓ replicated in a large n=766 cohort.[3]Serum Copper Assessment in Patients with Polycystic Ovary Syndrome and Tubal Infertility: A Retrospective 5-Year StudyLiu Y, Zhang W, Liu Z et al. · 2024Open reference 3 ↓
AMI/CVD: copper significantly elevated at 0.85 vs. 0.73 ug/mL (p < 0.01), remaining elevated 1 month post-intervention.[4]Plasma metallomics reveals potential biomarkers and insights into the ambivalent associations of elements with acute myocardial infarctionSi Ying Lim, Hiranya Dayal, Song Jie Seah et al. · 2023Open reference 4 ↓
Cancer: Elevated in breast,[5]Relationships Between Biological Heavy Metals and Breast Cancer: A Systematic Review and Meta-AnalysisLiu L, Chen J, Liu C et al. · 2022Open reference 5 ↓ prostate,[6]Serum Levels of Selenium, Zinc, Copper, Manganese, and Iron in Prostate Cancer PatientsSaleh A. K. Saleh, Heba M. Adly, Altaf A. Abdelkhaliq et al. · 2020Open reference 6 ↓ lung,[7]Metallomic Signatures of Lung Cancer and Chronic Obstructive Pulmonary DiseaseBelen Callejon-Leblic, Saida Sanchez Espirilla, Carolina Gotera-Rivera et al. · 2023Open reference 7 ↓ colorectal, pancreatic (ATP7A overexpression), and thyroid cancer.[1]Recent advances in the application of metallomics in diagnosis and prognosis of human cancerYan Zhang, Jie He, Jiao Jin et al. · 2022Open reference 1 ↓
PPD: Elevated serum copper in women with postpartum depression history.[8]Postpartum Depression and Role of Serum Trace ElementsEtebary S, Nikseresht S, Sadeghipour HR et al. · 2010Open reference 8 ↓ Schizophrenia: Elevated serum copper and ceruloplasmin correlate with symptom severity; copper displaces zinc (Zn) from NMDA receptor subunits (NR2A/NR2B), contributing to glutamatergic hypofunction.
Depression: High copper/zinc ratio is among the most replicated findings in biological psychiatry; free copper drives Fenton chemistry in neural tissue. IBD: copper rises as an acute-phase reactant in both ulcerative colitis flares and active Crohn's disease, correlating with CRP.
The critical exception is the brain in neurodegeneration.[9]Scholefield et al. 2024 — Brain Metallomic Signatures Distinguish DLB from AD and PDDMelissa Scholefield, Stephanie J. Church, Jingshu Xu et al. · 2024Open reference 9 ↓ found widespread copper decreases across all three dementias (DLB, AD, PDD) in post-mortem brain tissue. This paradox—peripheral copper excess with central copper deficiency—suggests disturbed copper trafficking rather than simple overload.
Ceruloplasmin dysfunction may be the link: it both elevates circulating copper and fails to deliver copper to the brain.
The emerging concept of cuproptosis (copper-dependent cell death via FDX1) adds a mechanistic layer, particularly in thyroid cancer.[10]Effects of Trace Elements on Endocrine Function and Pathogenesis of Thyroid Diseases — A Literature ReviewBrylinski L, Kostelecka K, Wolinski F et al. · 2025Open reference 10 ↓
Zinc: The Common Deficiency#
Zinc depletion runs through an extraordinary range of conditions, now encompassing 15+ disease entities in this wiki.
T2D: Urinary zinc (Zn) loss is a hallmark; ZnT8 transporter mutations associated with disease.[11]Metals in the pathogenesis of type 2 diabetesAbdul Rehman Khan, Fazli Rabbi Awan · 2014Open reference 11 ↓ T1D: ZnT8 is a major autoantigen (anti-ZnT8 antibodies in 60-80% of newly diagnosed); zinc is essential for insulin hexamer storage.
Breast cancer: Significantly lower in plasma/serum (SMD -2.09).[5]Relationships Between Biological Heavy Metals and Breast Cancer: A Systematic Review and Meta-AnalysisLiu L, Chen J, Liu C et al. · 2022Open reference 5 ↓ Prostate cancer: 0.51 vs. 0.82 ug/mL in healthy controls.[6]Serum Levels of Selenium, Zinc, Copper, Manganese, and Iron in Prostate Cancer PatientsSaleh A. K. Saleh, Heba M. Adly, Altaf A. Abdelkhaliq et al. · 2020Open reference 6 ↓
Colorectal cancer: European cohort of 58,221 confirmed significant association.[1]Recent advances in the application of metallomics in diagnosis and prognosis of human cancerYan Zhang, Jie He, Jiao Jin et al. · 2022Open reference 1 ↓
Autism: The most consistent finding in ASD metal studies is decreased hair zinc.[12]Metal Profiles in Autism Spectrum Disorders: A Crosstalk between Toxic and Essential MetalsBlazewicz A, Grabrucker AM · 2023Open reference 12 ↓ PPD: Serum zinc 2.5-fold lower in PPD cases; 100 mg/day supplementation OR 0.249 for PPD prevention.[13]The Possible Effects of Zinc Supplementation on Postpartum Depression and AnemiaAoki C, Imai K, Owaki T et al. · 2022Open reference 13 ↓
Depression: Severity inversely correlated with serum zinc; supplementation augments SSRI response.[14]Exposure to heavy metals and neurocognitive function in adults: a systematic reviewAlthomali RH, Abbood MA, Saleh EAM et al. · 2024Open reference 14 ↓ Schizophrenia: Depressed zinc contributes to NMDA hypofunction via loss of positive allosteric modulation; copper (Cu) displacement at synaptic zinc-binding sites creates functional deficiency.
Dysmenorrhea: zinc supplementation produces large pain reductions (Hedges's g = -1.541).[15]Efficacy of Zinc Supplementation in the Management of Primary Dysmenorrhea: A Systematic Review and Meta-AnalysisHsu TJ, Hsieh RH, Huang CH et al. · 2024Open reference 15 ↓
Thyroid/Hashimoto's: 49.1% prevalence of zinc deficiency in hypothyroid patients (OR 5.926); zinc necessary for TRH, TSH, T3, T4 production ([10]Effects of Trace Elements on Endocrine Function and Pathogenesis of Thyroid Diseases — A Literature ReviewBrylinski L, Kostelecka K, Wolinski F et al. · 2025Open reference 10 ↓[16]Recent advances of trace elements in autoimmune thyroid diseaseLi S, Xu Q, Wang S et al. · 2025Open reference 16 ↓).
Ulcerative colitis: Depleted, impairing mucosal healing and tight junction integrity.[17]Clinical and inflammatory biomarkers of inflammatory bowel diseases are linked to plasma trace elements and toxic metals; new insights into an old conceptAmerikanou C, Karavoltsos S, Gioxari A et al. · 2022Open reference 17 ↓ Crohn's disease: ZIP8 A391T variant alters zinc handling; Paneth cell defensins require zinc.[18]ZIP8 A391T Crohn's Disease-Linked Risk Variant Induces Colonic Metal Ion Dyshomeostasis, Microbiome Compositional Shifts, and InflammationYang JC, Zhao M, Chernikova D et al. · 2024Open reference 18 ↓
The mechanism connecting zinc depletion to such diverse diseases centers on zinc's role in over 300 metalloenzymes, DNA stabilization, immune regulation, and particularly copper/zinc superoxide dismutase (Cu/Zn-SOD) antioxidant defense.
Toxic metals (lead (Pb), cadmium (Cd), mercury (Hg)) may worsen zinc status by competing for protein binding sites, effectively creating functional zinc deficiency even when total body zinc is adequate.[19]Metal Dyshomeostasis as a Driver of Gut Pathology in Autism Spectrum DisordersO'Grady K, Grabrucker AM · 2025Open reference 19 ↓
The Cu/Zn Ratio: A Cross-Disease Biomarker#
The copper (Cu)/zinc (Zn) ratio deserves its own discussion because it captures two simultaneous changes in a single number. It is now documented as elevated in:
- All major cancers (breast, prostate, lung, colorectal, thyroid, pancreatic)[1]Recent advances in the application of metallomics in diagnosis and prognosis of human cancerYan Zhang, Jie He, Jiao Jin et al. · 2022Open reference 1 ↓
- PCOS[2]Serum Copper Level and Polycystic Ovarian Syndrome: A Meta-AnalysisJiang Q, Zhang F, Han L et al. · 2021Open reference 2 ↓
- AMI/CVD[4]Plasma metallomics reveals potential biomarkers and insights into the ambivalent associations of elements with acute myocardial infarctionSi Ying Lim, Hiranya Dayal, Song Jie Seah et al. · 2023Open reference 4 ↓
- Thyroid autoimmunity[10]Effects of Trace Elements on Endocrine Function and Pathogenesis of Thyroid Diseases — A Literature ReviewBrylinski L, Kostelecka K, Wolinski F et al. · 2025Open reference 10 ↓
- Schizophrenia (correlates with symptom severity)
- Depression (among the most replicated findings in biological psychiatry)
- Ulcerative colitis (correlates with disease activity)
- PPD[8]Postpartum Depression and Role of Serum Trace ElementsEtebary S, Nikseresht S, Sadeghipour HR et al. · 2010Open reference 8 ↓
The mechanistic basis: elevated copper displaces zinc from metallothionein due to higher binding affinity, simultaneously impairing copper/zinc superoxide dismutase (Cu/Zn-SOD) (SOD1) antioxidant defense and creating a pro-oxidant environment.
In schizophrenia specifically, copper displacement of zinc from NMDA receptor subunits and zinc-finger transcription factors may produce functional zinc deficiency at the synapse even when total body zinc appears adequate—providing a metallomic substrate for the NMDA hypofunction hypothesis.
Lead and Cadmium: Consistently Harmful Across All Systems#
Lead and Cadmium appear as elevated exposures in virtually every disease category examined in this wiki. Their harm is not disease-specific but systemic.
lead (Pb): Elevated in PCOS, breast cancer, T2D, Alzheimer's, RA, CKD, autism, lung cancer, thyroid disease, gastric cancer (occupational), hypertension (even at <10 ug/dL; eNOS inhibition, RAAS activation), endometriosis (peritoneal 75 vs 0.72 ug/L), depression (childhood exposure predicts adult MDD), and PPD.
cadmium (Cd): Similarly elevated across PCOS, breast cancer (metalloestrogen), T2D, neurodegeneration, CKD (increases risk from 10% to 25%), autism, lung cancer (smoking pathway), thyroid disease, gastric cancer (IARC Group 1), obesity (fecal cadmium inversely correlated with Bifidobacteriaceae), Crohn's disease (ZIP8 variant), colorectal cancer, ovarian cancer (metalloestrogen, ERa Kd 4.5e-10 M), and pancreatic cancer.
The CKD vicious cycle is particularly instructive: as kidney function declines, excretion of lead and cadmium diminishes, raising blood levels, which further damages the kidneys.[20]Susceptibility to Environmental Heavy Metal Toxicity among Americans with Kidney DiseaseDanziger J, Dodge LE, Hu H et al. · 2022Open reference 20 ↓
The hypertension-kidney axis adds another layer: lead and cadmium accumulate in renal cortex, damaging tubular function and impairing the kidney's central role in long-term blood pressure regulation.
Iron: Overload in Some, Deficiency in Others#
Iron is the metal most dependent on disease context, now with additional disease rows reinforcing its bidirectional pathology.
Overload/accumulation: Parkinson's (substantia nigra, ferroptosis),[21]Microbial Metallomics and Parkinson's Disease: A Unified Metal-Driven Framework Linking Ferroptosis, Dysbiosis, and alpha-Synuclein PathologyKaren Pendergrass · 2025Open reference 21 ↓ Alzheimer's (hippocampus/cortex),[22]Common and Trace Metals in Alzheimer's and Parkinson's DiseasesDoroszkiewicz J, Farhan JA, Mroczko J et al. · 2023Open reference 22 ↓ T2D (elevated ferritin, insulin resistance),[11]Metals in the pathogenesis of type 2 diabetesAbdul Rehman Khan, Fazli Rabbi Awan · 2014Open reference 11 ↓ endometriosis (peritoneal fluid iron, ferroptosis), T1D (islet overload, Fenton chemistry in beta cells), colorectal cancer (heme iron, N-nitroso compounds), multiple sclerosis (deep gray matter accumulation).
Depletion: AMI (acute decrease),[4]Plasma metallomics reveals potential biomarkers and insights into the ambivalent associations of elements with acute myocardial infarctionSi Ying Lim, Hiranya Dayal, Song Jie Seah et al. · 2023Open reference 4 ↓ Hashimoto's (58% anemic, TPO impairment),[10]Effects of Trace Elements on Endocrine Function and Pathogenesis of Thyroid Diseases — A Literature ReviewBrylinski L, Kostelecka K, Wolinski F et al. · 2025Open reference 10 ↓ Graves' disease, PPD (ferritin < 1 ug = 3.98x risk), ulcerative colitis (60-80% iron (Fe) deficient from chronic bleeding), depression (ferritin <30 ng/mL associates with symptoms even without anemia).
Functional redistribution: Crohn's disease exemplifies dual mechanisms—true deficiency from bleeding/malabsorption coexists with hepcidin-mediated functional withholding (nutritional immunity). Iron supplementation in this context may feed siderophore-producing pathogens without correcting the underlying problem.
The concept of ferroptosis—iron-dependent lipid peroxidation cell death—now bridges an expanding set of diseases: Parkinson's, CKD, thyroid cancer, ovarian cancer (therapeutic target in cisplatin-resistant cells), endometriosis, and T1D (beta cell death releasing neoantigens).
Selenium: The Thyroid Protector and Beyond#
Selenium depletion is now most strongly characterized in thyroid autoimmunity, where it has moved from association to therapeutic intervention.
Hashimoto's thyroiditis: 200 ug selenium (Se)/day reduces anti-TPO antibodies by up to 40% in patients with levels >1200 IU/mL;[23]McGregor Brock 2015 — The Role of Selenium in Thyroid Autoimmunity: A ReviewMcGregor Brock · 2015Open reference 23 ↓ selenium modulates Th1/Th2/Th17/Treg balance and protects against H2O2-mediated thyrocyte damage.
Graves' ophthalmopathy: 200 ug selenium/day for 6 months decreased severity, improved quality of life; benefits persisted after therapy withdrawal.[23]McGregor Brock 2015 — The Role of Selenium in Thyroid Autoimmunity: A ReviewMcGregor Brock · 2015Open reference 23 ↓
Cancer: Depleted across breast, prostate, colorectal, lung, and pancreatic cancers; impairs glutathione peroxidase defense. CVD: Persistent depletion post-MI.[4]Plasma metallomics reveals potential biomarkers and insights into the ambivalent associations of elements with acute myocardial infarctionSi Ying Lim, Hiranya Dayal, Song Jie Seah et al. · 2023Open reference 4 ↓
Metal antagonism: selenium reduces cadmium levels by direct binding and biliary excretion; antagonistic relationship with mercury—critical for Hashimoto's patients with concurrent mercury (Hg) exposure.
The thyroid contains the highest selenium concentration of any organ because deiodinases (DIO1/2/3), glutathione peroxidases, and thioredoxin reductases are all selenoproteins. selenium deficiency impairs T4-to-T3 conversion, thyrocyte protection, and Treg function simultaneously.
3. Mismetallation Across Diseases#
Mismetallation—the substitution of the wrong metal ion into an enzyme's active site—is emerging as a unifying mechanism across the disease landscape. Rather than simple toxicity from metal excess, mismetallation produces disease-specific patterns by disrupting specific metalloproteins in specific tissues.
3.1 Copper Displacing Zinc#
The most pervasive mismetallation pattern. Because copper (Cu) has higher binding affinity than zinc (Zn) for most metal-binding sites, copper excess systematically displaces zinc.
SOD1 (copper/zinc superoxide dismutase (Cu/Zn-SOD)): The master cytoplasmic antioxidant enzyme requires both copper and zinc. Excess free copper combined with zinc depletion—the dominant pattern in the matrix—directly compromises SOD1 function. Relevant to: cancer, CVD, PCOS, T2D, IBD, and every condition with copper/zinc ratio elevation.
NMDA receptors (NR2A/NR2B): Zinc is an endogenous positive allosteric modulator. copper displacement at NR2A/NR2B subunits creates functional zinc deficiency at the synapse, contributing to glutamatergic hypofunction. This provides a metallomic substrate for the NMDA hypofunction hypothesis of schizophrenia and contributes to cognitive symptoms in depression.
Zinc-finger transcription factors: copper can displace zinc from zinc-finger motifs, disrupting DNA-binding and gene regulation. Documented in cancer cell lines and proposed in neuropsychiatric disorders.
GABAergic interneuron proteins: copper excess inhibits GABAergic neurotransmission, contributing to excitatory/inhibitory imbalance in schizophrenia and depression.
Metallothionein: copper's higher affinity displaces zinc from metallothionein, the primary intracellular metal-buffering protein. This creates a vicious cycle: the displaced zinc is lost, copper occupies the buffer, and subsequent copper cannot be properly sequestered.
3.2 Cadmium Displacing Zinc#
Cadmium is a particularly effective zinc (Zn) mimic because of similar ionic radius and charge.
DNA-binding motifs: cadmium (Cd) replaces zinc in DNA repair enzymes and transcription factors, inhibiting DNA repair while promoting mutagenesis—the basis of cadmium's IARC Group 1 carcinogenesis without forming stable DNA adducts.[24]Exposure to Cadmium and Its Impacts on Human Health: A Short ReviewPuthiyavalappil Rasin, Ashwathi A V, Sabeel M Basheer et al. · 2025Open reference 24 ↓
Metallothionein: cadmium displaces zinc from metallothionein, simultaneously eliminating a zinc reservoir and a cadmium detoxification pathway.[6]Serum Levels of Selenium, Zinc, Copper, Manganese, and Iron in Prostate Cancer PatientsSaleh A. K. Saleh, Heba M. Adly, Altaf A. Abdelkhaliq et al. · 2020Open reference 6 ↓
ZIP8 transporter: The A391T variant in Crohn's disease alters cadmium handling at the colonic mucosa, with higher cadmium accumulation in tissue.[18]ZIP8 A391T Crohn's Disease-Linked Risk Variant Induces Colonic Metal Ion Dyshomeostasis, Microbiome Compositional Shifts, and InflammationYang JC, Zhao M, Chernikova D et al. · 2024Open reference 18 ↓
Competitive absorption: cadmium and zinc share intestinal absorption pathways (DMT1, ZIP transporters). Iron deficiency increases cadmium absorption in women, creating a secondary risk.[25]Role of Cadmium and Nickel in Estrogen Receptor Signaling and Breast Cancer: Metalloestrogens or Not?Aquino NB, Sevigny MB, Sabangan J et al. · 2012Open reference 25 ↓
Functional zinc deficiency in ASD: Toxic metals (cadmium, lead (Pb), mercury (Hg)) compete for zinc-binding protein sites, creating functional zinc deficiency even with adequate total body zinc—the unifying mechanism proposed for ASD gut pathology.[19]Metal Dyshomeostasis as a Driver of Gut Pathology in Autism Spectrum DisordersO'Grady K, Grabrucker AM · 2025Open reference 19 ↓
3.3 Lead Mimicking Calcium#
lead (Pb) and calcium(II) (Ca2+) have similar ionic radii, allowing lead to enter calcium channels and mimic calcium signaling. Neurotransmitter release: lead triggers spontaneous neurotransmitter release by substituting for calcium(II) at presynaptic terminals, disrupting synaptic plasticity.[22]Common and Trace Metals in Alzheimer's and Parkinson's DiseasesDoroszkiewicz J, Farhan JA, Mroczko J et al. · 2023Open reference 22 ↓
PKC activation: lead activates protein kinase C at picomolar concentrations (calcium requires micromolar), producing chronic, low-grade kinase activation. Calmodulin binding: lead binds calmodulin with higher affinity than calcium, disrupting calcium-dependent enzyme cascades.
Endometriosis: Peritoneal lead at 75 ug/L (vs 0.72 ug/L in controls) enters cells through calcium channels, disrupting signaling in endometrial tissue.[26]Elevated Lead, Nickel, and Bismuth Levels in the Peritoneal Fluid of a Peritoneal Endometriosis Patient without Toxic Habits or Occupational Exposure following a Vegetarian DietLopez-Botella A, Gomez-Torres MJ, Sanchez R et al. · 2023Open reference 26 ↓
Hypertension: lead inhibits endothelial nitric oxide synthase and activates the RAAS system, contributing to sustained blood pressure elevation even at blood levels below 10 ug/dL.
3.4 Nickel Replacing Iron#
nickel (Ni)(II) is close in ionic radius to iron (Fe)(II), enabling it to substitute in iron-dependent enzymes. HIF-prolyl hydroxylases: nickel replaces iron(II), stabilizing HIF-1alpha and activating hypoxic signaling under normoxic conditions—a hallmark of nickel carcinogenesis.[27]Genetic and Epigenetic Mechanisms in Metal Carcinogenesis and Cocarcinogenesis: Nickel, Arsenic, and ChromiumKonstantin Salnikov, Anatoly Zhitkovich · 2008Open reference 27 ↓
JMJD2 demethylases: nickel inhibits these iron-dependent 2OG-dependent dioxygenases, altering histone methylation patterns and silencing tumor suppressor genes. Iron-containing hydroxylases: nickel depletes intracellular ascorbate (required as cofactor), further impairing iron-dependent enzyme function.
Thyroid function: nickel at blood levels of 1.36-60.9 ug/L reduces fT4 and SPINA-GT through oxidative stress and apoptotic disruption in thyroid tissue, potentially involving iron-dependent deiodinase interference.[28]Nickel as a potential disruptor of thyroid function: benchmark modelling of human dataMaric D, Baralic K, Javorac D et al. · 2023Open reference 28 ↓
3.5 Disease-Specific Mismetallation Patterns#
The four mismetallation pathways above create characteristic patterns in specific diseases:
| Disease | Primary Mismetallation | Consequence |
|---|---|---|
| Schizophrenia | copper (Cu)→zinc (Zn) at NMDA receptors | Glutamatergic hypofunction, GABAergic imbalance |
| Depression | copper→zinc at SOD1, synaptic sites | Oxidative stress, monoamine disruption |
| Cancer (general) | cadmium (Cd)→zinc in DNA repair; nickel (Ni)→iron (Fe) in HIF hydroxylases | Mutagenesis + hypoxic signaling |
| Gastric cancer | nickel→iron in host enzymes + nickel fueling H. pylori | Combined host damage and pathogen virulence |
| Alzheimer's | lead (Pb)→calcium (Ca) in signaling; copper→zinc in plaques | Amyloid aggregation, synaptic dysfunction |
| T1D | iron overload in islets; cadmium→zinc in beta cell proteins | Beta cell destruction, neoantigen generation |
| CKD | cadmium→zinc in tubular proteins; iron-driven ferroptosis | Progressive nephron loss |
| Endometriosis | lead→calcium in endometrial cells; cadmium→zinc in repair enzymes | Proliferation + DNA damage |
4.1 Oxidative Stress: SOD/CAT/MDA/GPx Disruption#
Virtually every metal-disease association in this wiki traces through oxidative stress. The mechanism is direct: toxic metals (lead (Pb), cadmium (Cd), mercury (Hg), arsenic (As), nickel (Ni)) generate reactive oxygen species while simultaneously depleting the enzymatic defenses against them.
copper/zinc superoxide dismutase (Cu/Zn-SOD) (SOD1): Requires both copper and zinc as cofactors. copper excess and zinc depletion—the dominant pattern in the matrix—directly compromise SOD1 function.[5]Relationships Between Biological Heavy Metals and Breast Cancer: A Systematic Review and Meta-AnalysisLiu L, Chen J, Liu C et al. · 2022Open reference 5 ↓
manganese (Mn)-SOD (SOD2): manganese depletion in breast cancer and other conditions reduces mitochondrial antioxidant capacity.
Glutathione peroxidase (GPx): selenium (Se)-dependent; selenium depletion across cancers, CVD, and thyroid disease impairs this critical defense. In PCOS, GSH was significantly decreased (6.24 vs. 8.09 mg/mL, p < 0.001) alongside elevated toxic metals.[29]Antioxidant Status in Relation to Heavy Metals Induced Oxidative Stress in Patients with Polycystic Ovarian Syndrome (PCOS)Manal Abudawood, Hajera Tabassum, Atheer H. Alanazi et al. · 2021Open reference 29 ↓
Catalase (CAT): Inhibited by lead, cadmium, and nickel; reduced activity documented in PCOS, T2D, and neurodegeneration.
MDA (malondialdehyde): As the end product of lipid peroxidation, MDA is elevated in virtually all metal-associated diseases, serving as a universal marker of oxidative damage.
Nickel's relationship to oxidative stress involves an additional unique mechanism: depletion of intracellular ascorbate, which impairs the function of iron-containing hydroxylases and DNA repair enzymes.[27]Genetic and Epigenetic Mechanisms in Metal Carcinogenesis and Cocarcinogenesis: Nickel, Arsenic, and ChromiumKonstantin Salnikov, Anatoly Zhitkovich · 2008Open reference 27 ↓
4.2 Gut Barrier Disruption: Tight Junctions as Metal Targets#
The intestinal epithelial barrier is a first-line target of dietary metal exposure.[30]Effects of Heavy Metals on Gut Barrier Integrity and Gut MicrobiotaSweta Ghosh, Syam P. Nukavarpu, Venkatakrishna Rao Jala · 2024Open reference 30 ↓ provides the most comprehensive mapping. Arsenic: Disrupts colonic epithelial structure, increases paracellular transport, induces IL-6, IL-8, TNF-alpha. Lead: Reduces MUC2, ZO-1, claudin-1, occludin expression.
Mercury: Downregulates claudin-1, occludin, ZO-1, JAM1.
Cadmium: Reduces ZO-1, ZO-2, JAM-A, occludin, claudin-1; low doses decrease Akkermansia muciniphila. Chromium: Hexavalent chromium (Cr) downregulates ZO-1, occludin, claudin-1, MUC2; activates NLRP3 inflammasome.
These effects connect dietary metal exposure to diseases as apparently remote as Parkinson's (gut-brain axis), obesity (metabolic endotoxemia), schizophrenia (bacterial translocation with SMD 2.72 for anti-endotoxin antibodies), depression (leaky gut-TLR4-neuroinflammation pathway), and hypertension (SCFA depletion removing vasodilatory brake).
Zinc deficiency and heavy metal exposure produce overlapping gut pathologies—intestinal barrier dysfunction, permeability, inflammation, structural damage, and dysbiosis—converging in a Venn diagram where gut inflammation and barrier dysfunction occupy the center.[19]Metal Dyshomeostasis as a Driver of Gut Pathology in Autism Spectrum DisordersO'Grady K, Grabrucker AM · 2025Open reference 19 ↓
4.3 Epigenetic Modification: DNA Methylation and Histone Changes#
Metals alter gene expression without changing DNA sequence, creating long-lasting or transgenerational effects. Nickel: Induces DNA hypermethylation, silencing tumor suppressor genes (p16 promoter hypermethylation in all nickel (Ni)-transformed cells); causes loss of histone H3/H4 acetylation and increased H3K9 dimethylation.[27]Genetic and Epigenetic Mechanisms in Metal Carcinogenesis and Cocarcinogenesis: Nickel, Arsenic, and ChromiumKonstantin Salnikov, Anatoly Zhitkovich · 2008Open reference 27 ↓
Arsenic: Causes both hypo- and hypermethylation; depletes SAM because arsenic's own detoxification via methylation consumes SAM.[27]Genetic and Epigenetic Mechanisms in Metal Carcinogenesis and Cocarcinogenesis: Nickel, Arsenic, and ChromiumKonstantin Salnikov, Anatoly Zhitkovich · 2008Open reference 27 ↓ Cadmium: Epigenetic carcinogenesis without forming stable DNA adducts; suppresses DNA repair, disrupts apoptosis.[24]Exposure to Cadmium and Its Impacts on Human Health: A Short ReviewPuthiyavalappil Rasin, Ashwathi A V, Sabeel M Basheer et al. · 2025Open reference 24 ↓
Lead: Early-life exposure produces latent effects on AD-related gene expression through epigenetic mechanisms that manifest decades later;[31]Heavy Metals Exposure and Alzheimer's Disease and Related DementiasBakulski KM, Seo YA, Hickman RC et al. · 2020Open reference 31 ↓ childhood lead (Pb) exposure predicts adult depression through similar epigenetic pathways.
4.4 Endocrine Disruption: Metalloestrogens and Thyroid Interference#
Metals interfere with hormonal signaling through multiple mechanisms.
Metalloestrogens: Cadmium binds ERa with affinity nearly equivalent to estradiol (Kd 4.5 x 10^-10 M). Nickel also binds ERa, increasing cell growth 2-5 fold in MCF-7 cells.[25]Role of Cadmium and Nickel in Estrogen Receptor Signaling and Breast Cancer: Metalloestrogens or Not?Aquino NB, Sevigny MB, Sabangan J et al. · 2012Open reference 25 ↓ This has direct relevance to breast cancer, PCOS, endometriosis, and ovarian cancer.
Thyroid disruption: Multiple metals converge.
selenium (Se) deficiency impairs deiodinases (T4-to-T3); cadmium (Cd) inhibits 5'-monodeiodinase; lead (Pb) blocks deiodination; mercury (Hg) inhibits TPO and Tg iodination; nickel (Ni) shows dose-response relationships with decreased fT4 and SPINA-GT; excess iodine paradoxically activates NLRP3 inflammasome and promotes Th17 proliferation in Hashimoto's ([10]Effects of Trace Elements on Endocrine Function and Pathogenesis of Thyroid Diseases — A Literature ReviewBrylinski L, Kostelecka K, Wolinski F et al. · 2025Open reference 10 ↓[28]Nickel as a potential disruptor of thyroid function: benchmark modelling of human dataMaric D, Baralic K, Javorac D et al. · 2023Open reference 28 ↓).
Reproductive hormones: nickel correlates with estradiol and LH in PCOS;[32]Levels of Trace Elements in Erythrocytes as Endocrine Disruptors in Obese and Nonobese Women with Polycystic Ovary SyndromeKamila Pokorska-Niewiada, Agnieszka Brodowska, Jacek Brodowski et al. · 2022Open reference 32 ↓ copper (Cu) excess inhibits GABAergic neurotransmission affecting HPA axis regulation in depression and schizophrenia.
4.5 Immune Dysregulation: NF-kB and Cytokine Cascades#
Metals perturb immune function through overlapping inflammatory pathways. NF-kB activation: As activates NF-kB at low concentrations; cadmium (Cd) activates it in CKD via MAPK; iron (Fe) overload activates it in T1D islets.
Cytokine shifts: lead (Pb) and mercury (Hg) trigger glial reactivity (TNF-alpha, IL-1, IL-6); nickel (Ni) challenge induces IL-5 increase and CD4+CD45RO+ cell infiltration in intestinal mucosa;[33]Systemic Nickel Allergy SyndromeDi Gioacchino M, Gatta A, Della Valle L et al. · 2018Open reference 33 ↓ copper (Cu)/zinc (Zn) imbalance in schizophrenia shifts toward Th17-dominant inflammation.
Th1/Th2/Th17/Treg balance: Disrupted by metals across autoimmune conditions: RA, Hashimoto's (selenium (Se) modulates), Graves', T1D (zinc deficiency reduces Treg function), schizophrenia (Th17 skewing), and MS.
NLRP3 inflammasome: Activated by hexavalent chromium (Cr) in gut epithelium; by excess iodine in Hashimoto's; by iron overload in T1D beta cells.
5. The Nickel Hub#
Nickel is the central entity of this wiki, and its connections to the broader metal toxicology picture are distinctive in several ways.
5.1 Nickel Allergy as Gateway to Systemic Effects#
Nickel allergy (affecting up to 17.6% of some populations, with strong female predominance) is not merely a skin condition. systemic-nickel-allergy-syndrome (SNAS) involves both cutaneous and gastrointestinal manifestations triggered by dietary nickel exposure.
SNAS affects approximately 20% of allergic contact dermatitis patients and is associated with lactose intolerance in 63-74% of cases.[33]Systemic Nickel Allergy SyndromeDi Gioacchino M, Gatta A, Della Valle L et al. · 2018Open reference 33 ↓
The expanded disease matrix now reveals that nickel sensitivity clusters with specific conditions: GERD (95% of refractory patients improve on low-nickel (Ni) diet), IBS (30-65% nickel sensitization), endometriosis (90.3% nickel ACM), and obesity (59.7% of overweight women are nickel-allergic).
This clustering suggests nickel allergy may be a visible marker of a much broader immune and metabolic sensitivity.
5.2 Nickel's Unique Dual Role: Toxic to Host, Essential to Pathogens#
The two-kingdom conundrum: mammals do not synthesize any known nickel-requiring proteins, yet nickel is essential for the virulence of at least 40 prokaryotic and 9 eukaryotic pathogens.[34]Role of Nickel in Microbial PathogenesisRobert J. Maier, Stéphane L. Benoit · 2019Open reference 34 ↓
This is uniquely relevant to gastric cancer, where the chain nickel (Ni) → urease/hydrogenase → H. pylori colonization → CagA translocation → carcinogenesis is one of the most direct metal-to-cancer pathways in human disease.
The host's defense includes nutritional immunity—sequestering nickel via calprotectin (which preferentially coordinates nickel(II) over zinc (Zn)(II) at its hexahistidine site), lactoferrin, and NRAMP1 export from macrophage phagolysosomes.
5.3 Nickel in Food: The Dietary Paradox#
Full evidence is maintained on the canonical paradox article.
6. Diagnostic Potential: Metallomics as a Clinical Tool#
6.1 Metallomic Signature Tiers (Scholefield 2024 Framework)#
[9]Scholefield et al. 2024 — Brain Metallomic Signatures Distinguish DLB from AD and PDDMelissa Scholefield, Stephanie J. Church, Jingshu Xu et al. · 2024Open reference 9 ↓ proposed a three-tier framework for metallomic signatures that applies beyond dementia:
Tier 1—Universal metallomic disturbance: Patterns shared across multiple diseases (elevated copper (Cu), depleted zinc (Zn), elevated lead (Pb)/cadmium (Cd)). These have high sensitivity but low specificity. Useful for screening but not differential diagnosis.
Tier 2—Disease-class signatures: Patterns that distinguish disease categories (e.g., cancers share ↑copper/↓zinc/↓selenium (Se)/↑cadmium; autoimmune thyroid diseases share ↓selenium/↓iron (Fe)/↑cadmium/↑mercury (Hg); neurodegenerative diseases share brain copper depletion with peripheral copper elevation). Useful for narrowing differential diagnosis.
Tier 3—Disease-specific signatures: Patterns unique to individual diseases. Examples include: pancreatic cancer (zinc isotope fractionation, abolished zinc/copper correlation); lung cancer vs. COPD discrimination (aluminum (Al), manganese (Mn), nickel (Ni) ratios); dementia subtyping (post-mortem brain metallomics separating DLB from AD from PDD by PCA/PLS-DA using as few as three brain regions).
ADVERSARIAL CAVEAT—Discovery-study limitation: Nearly all metallomic signatures described in this wiki are discovery-phase findings. They have not been prospectively validated in independent cohorts, are not standardized across laboratories, and lack established clinical reference ranges.
The diagnostic AUC values reported (e.g., 0.99 for pancreatic cancer urine metallomics, 0.942 for AMI copper/selenium ratio) are from the same cohorts that generated the signatures and are therefore likely overestimates due to overfitting. These findings should be treated as hypothesis-generating, not ready for clinical deployment.
6.2 Disease-Discriminating Metal Panels#
Cancer (general): ↑copper (Cu), ↓zinc (Zn), ↓selenium (Se), ↑cadmium (Cd)—this four-element signature appears across breast, prostate, colorectal, lung, and pancreatic cancers.[1]Recent advances in the application of metallomics in diagnosis and prognosis of human cancerYan Zhang, Jie He, Jiao Jin et al. · 2022Open reference 1 ↓
AMI/CVD: ↑copper, ↓selenium, ↓iron (Fe), with copper/selenium ratio achieving AUC of 0.942 when combined with traditional risk factors.[4]Plasma metallomics reveals potential biomarkers and insights into the ambivalent associations of elements with acute myocardial infarctionSi Ying Lim, Hiranya Dayal, Song Jie Seah et al. · 2023Open reference 4 ↓ Lung cancer vs. COPD: aluminum (Al), manganese (Mn), nickel (Ni) ratios distinguish COPD patients who will develop cancer.[7]Metallomic Signatures of Lung Cancer and Chronic Obstructive Pulmonary DiseaseBelen Callejon-Leblic, Saida Sanchez Espirilla, Carolina Gotera-Rivera et al. · 2023Open reference 7 ↓
Dementia subtyping: Post-mortem brain metallomics using as few as three regions can separate DLB from AD from PDD.[9]Scholefield et al. 2024 — Brain Metallomic Signatures Distinguish DLB from AD and PDDMelissa Scholefield, Stephanie J. Church, Jingshu Xu et al. · 2024Open reference 9 ↓
Pancreatic cancer: Urine metallomics (calcium (Ca), magnesium (Mg), zinc, copper panel) achieves AUC 0.99, with zinc isotope fractionation as a novel dimension.[35]Urine metallomics signature as an indicator of pancreatic cancerKathrin Schilling, Fiona Larner, Amina Saad et al. · 2020Open reference 35 ↓
Schizophrenia: copper/zinc ratio correlates with symptom severity and may complement virome-based classifiers (AUC 0.932 for virome alone).
6.3 Metal Ratios as Emerging Biomarkers#
Individual metal concentrations are noisy. Ratios capture the balance between pro-oxidant and antioxidant metals, amplifying signal.
copper (Cu)/zinc (Zn) ratio: Elevated across virtually all cancers, PCOS, CVD, thyroid cancer, schizophrenia, depression, and UC. The single most reproducible metallomic biomarker. copper/selenium (Se) ratio: Increased in AMI; incorporated into random forest models achieving 0.942 AUC.[4]Plasma metallomics reveals potential biomarkers and insights into the ambivalent associations of elements with acute myocardial infarctionSi Ying Lim, Hiranya Dayal, Song Jie Seah et al. · 2023Open reference 4 ↓
iron (Fe)/copper ratio: Significantly decreased in AMI (p < 0.0001).[4]Plasma metallomics reveals potential biomarkers and insights into the ambivalent associations of elements with acute myocardial infarctionSi Ying Lim, Hiranya Dayal, Song Jie Seah et al. · 2023Open reference 4 ↓
zinc concentration/copper concentration correlation: Abolished in pancreatic cancer (r2 drops from 0.66 to 0.0002), indicating fundamental disruption of metal homeostasis.[35]Urine metallomics signature as an indicator of pancreatic cancerKathrin Schilling, Fiona Larner, Amina Saad et al. · 2020Open reference 35 ↓
6.4 Biological Matrix Selection#
| Matrix | Exposure window | Best for | Limitations |
|---|---|---|---|
| Blood/serum | Acute (days-weeks) | Current status; most metals | Homeostatic regulation masks chronic exposure |
| Whole blood | Short-medium term | lead (Pb) (erythrocyte-bound), mercury (Hg) | Does not distinguish free vs. bound metal |
| Urine | Recent (hours-days) | cadmium (Cd), nickel (Ni), arsenic (As), chromium (Cr); pancreatic cancer panel | Affected by kidney function (CKD underestimates) |
| Hair | Chronic (months) | ASD metal profiles (most consistent zinc (Zn) finding) | External contamination; growth rate varies |
| Toenails | Chronic (6-12 months) | Breast cancer studies | Less sensitive; null results more common |
| Bone (tibia/patella) | Cumulative lifetime | lead in Alzheimer's research | Requires K-XRF; not routine |
| Erythrocytes | Medium term (120 days) | PCOS nickel | Requires separation; less standardized |
| Brain tissue | Lifetime regional accumulation | Dementia subtyping | Post-mortem only (currently) |
| Peritoneal fluid | Local environment | Endometriosis (nickel 40.4 ug/L, lead 75 ug/L) | Surgical access required |
| Fecal | Dietary/microbial interface | Obesity (cadmium, iron (Fe), manganese (Mn), zinc) | Variable composition; emerging methodology |
A key insight: bone lead is a far better predictor of Alzheimer's risk than blood lead, yet most studies use blood because it is easier to obtain. The choice of matrix can determine whether an association is found or missed entirely.
7. Intervention Evidence#
The metal-disease associations documented in Sections 1–6 inform a growing body of intervention research.
Detailed evidence for specific interventions—including low-nickel dietary protocols, zinc and selenium supplementation, iron management strategies, probiotic strain selection, FMT, and oral hyposensitization—is catalogued in the corresponding intervention and STOP pages within the Cureva practitioner platform, where clinical context and evidence grading support practitioner decision-making.
8. Convergence#
The 1,426 source pages in this wiki describe individual threads. This matrix reveals where those threads converge:
- Copper and zinc are the master biomarkers. copper (Cu)/zinc (Zn) ratio elevation is the single most reproducible metallomic finding across cancer, cardiovascular disease, PCOS, thyroid disease, schizophrenia, depression, PPD, and IBD. This ratio captures the simultaneous failure of antioxidant defense (zinc-SOD depletion) and pro-oxidant accumulation (free copper).
- Mismetallation is the unifying mechanism. The four mismetallation patterns—copper displacing zinc, cadmium (Cd) displacing zinc, lead (Pb) mimicking calcium (Ca), nickel (Ni) replacing iron (Fe)—create disease-specific pathology by disrupting specific metalloproteins in specific tissues. This is not simple toxicity; it is targeted molecular sabotage that produces characteristic clinical phenotypes.
- Lead and cadmium are universal toxicants. Their elevation in every disease category suggests that reducing environmental lead and cadmium exposure would have broad health benefits transcending any single disease. The new disease rows (hypertension, obesity, depression, T1D, gastric cancer) only reinforce this pattern.
- The gut is the gateway. Dietary metal exposure first disrupts the intestinal barrier, reshapes the microbiome, and triggers systemic inflammation. This positions the gut as the critical intervention point—whether through diet (low-nickel, low-metal), probiotics (metal-specific strains), FMT, or barrier-protective nutrients. The expanded FMT evidence (ulcerative colitis, hypertension, Parkinson's) confirms microbial modulation has real physiological effects, even if transient.
- Iron is the wild card. Its dual nature—essential yet lethal via ferroptosis—makes it the metal most resistant to simple guidance. The expanded matrix adds T1D islet overload, UC bleeding depletion, and the critical IBD distinction between true deficiency and hepcidin-mediated functional withholding.
- Nickel occupies a unique niche. It is the only metal in this matrix that is simultaneously irrelevant to host biochemistry, essential to pathogen virulence, a common dietary exposure, a potent allergen, and an endocrine disruptor. The expanded disease list (11 conditions now with low-nickel diet evidence) strengthens its position as the natural hub of this wiki.
- Selenium is the thyroid guardian. With therapeutic evidence in Hashimoto's, Graves' ophthalmopathy, and pregnancy thyroiditis, selenium (Se) supplementation is the best-established mineral intervention for autoimmune thyroid disease. Its dual role as antioxidant enzyme cofactor and heavy metal antagonist makes it uniquely protective.
- Metallomics is promising but unvalidated. Multi-element profiling with machine learning can achieve AUC values exceeding 0.9 for disease discrimination. But these are discovery-phase findings. The barrier is no longer analytical but translational—standardizing sample collection, establishing reference ranges, validating in independent cohorts, and integrating metallomic data into clinical decision-making. Until prospective validation studies are completed, these associations remain hypothesis-generating.
References 62
Numbered by first appearance in the article, then reconciled with its declared source list.
- 1
Yan Zhang, Jie He, Jiao Jin et al. (2022). Recent advances in the application of metallomics in diagnosis and prognosis of human cancer. Metallomics.
- 2
Jiang Q, Zhang F, Han L et al. (2021). Serum Copper Level and Polycystic Ovarian Syndrome: A Meta-Analysis. Gynecologic and Obstetric Investigation.
- 3
Liu Y, Zhang W, Liu Z et al. (2024). Serum Copper Assessment in Patients with Polycystic Ovary Syndrome and Tubal Infertility: A Retrospective 5-Year Study. Food Science & Nutrition.
- 4
Si Ying Lim, Hiranya Dayal, Song Jie Seah et al. (2023). Plasma metallomics reveals potential biomarkers and insights into the ambivalent associations of elements with acute myocardial infarction. Journal of Trace Elements in Medicine and Biology.
- 5
★Liu L, Chen J, Liu C et al. (2022). Relationships Between Biological Heavy Metals and Breast Cancer: A Systematic Review and Meta-Analysis. Frontiers in Nutrition.
- 6
★Saleh A. K. Saleh, Heba M. Adly, Altaf A. Abdelkhaliq et al. (2020). Serum Levels of Selenium, Zinc, Copper, Manganese, and Iron in Prostate Cancer Patients. Current Urology.
- 7
Belen Callejon-Leblic, Saida Sanchez Espirilla, Carolina Gotera-Rivera et al. (2023). Metallomic Signatures of Lung Cancer and Chronic Obstructive Pulmonary Disease. International Journal of Molecular Sciences.
- 8
Etebary S, Nikseresht S, Sadeghipour HR et al. (2010). Postpartum Depression and Role of Serum Trace Elements. Iranian Journal of Psychiatry.
- 9
★Melissa Scholefield, Stephanie J. Church, Jingshu Xu et al. (2024). Scholefield et al. 2024 — Brain Metallomic Signatures Distinguish DLB from AD and PDD. Frontiers in Neuroscience.
- 10
★Brylinski L, Kostelecka K, Wolinski F et al. (2025). Effects of Trace Elements on Endocrine Function and Pathogenesis of Thyroid Diseases — A Literature Review. Nutrients.
- 11
★Abdul Rehman Khan, Fazli Rabbi Awan (2014). Metals in the pathogenesis of type 2 diabetes. Journal of Diabetes and Metabolic Disorders.
- 12
Blazewicz A, Grabrucker AM (2023). Metal Profiles in Autism Spectrum Disorders: A Crosstalk between Toxic and Essential Metals. International Journal of Molecular Sciences.
- 13
Aoki C, Imai K, Owaki T et al. (2022). The Possible Effects of Zinc Supplementation on Postpartum Depression and Anemia. Medicina.
- 14
Althomali RH, Abbood MA, Saleh EAM et al. (2024). Exposure to heavy metals and neurocognitive function in adults: a systematic review. Environmental Sciences Europe.
- 15
Hsu TJ, Hsieh RH, Huang CH et al. (2024). Efficacy of Zinc Supplementation in the Management of Primary Dysmenorrhea: A Systematic Review and Meta-Analysis. Nutrients.
- 16
Li S, Xu Q, Wang S et al. (2025). Recent advances of trace elements in autoimmune thyroid disease. Frontiers in Immunology.
- 17
Amerikanou C, Karavoltsos S, Gioxari A et al. (2022). Clinical and inflammatory biomarkers of inflammatory bowel diseases are linked to plasma trace elements and toxic metals; new insights into an old concept. Frontiers in Nutrition.
- 18
★Yang JC, Zhao M, Chernikova D et al. (2024). ZIP8 A391T Crohn's Disease-Linked Risk Variant Induces Colonic Metal Ion Dyshomeostasis, Microbiome Compositional Shifts, and Inflammation. Digestive Diseases and Sciences.
- 19
★O'Grady K, Grabrucker AM (2025). Metal Dyshomeostasis as a Driver of Gut Pathology in Autism Spectrum Disorders. Journal of Neurochemistry.
- 20
Danziger J, Dodge LE, Hu H et al. (2022). Susceptibility to Environmental Heavy Metal Toxicity among Americans with Kidney Disease. Kidney360.
- 21
★Karen Pendergrass (2025). Microbial Metallomics and Parkinson's Disease: A Unified Metal-Driven Framework Linking Ferroptosis, Dysbiosis, and alpha-Synuclein Pathology. Conference Presentation.
- 22
Doroszkiewicz J, Farhan JA, Mroczko J et al. (2023). Common and Trace Metals in Alzheimer's and Parkinson's Diseases. International Journal of Molecular Sciences.
- 23
McGregor Brock (2015). McGregor Brock 2015 — The Role of Selenium in Thyroid Autoimmunity: A Review. Journal of Restorative Medicine.
- 24
★Puthiyavalappil Rasin, Ashwathi A V, Sabeel M Basheer et al. (2025). Exposure to Cadmium and Its Impacts on Human Health: A Short Review. Journal of Hazardous Materials Advances.
- 25
★Aquino NB, Sevigny MB, Sabangan J et al. (2012). Role of Cadmium and Nickel in Estrogen Receptor Signaling and Breast Cancer: Metalloestrogens or Not?. Journal of Environmental Science and Health Part C - Environmental Carcinogenesis and Ecotoxicology Reviews.
- 26
Lopez-Botella A, Gomez-Torres MJ, Sanchez R et al. (2023). Elevated Lead, Nickel, and Bismuth Levels in the Peritoneal Fluid of a Peritoneal Endometriosis Patient without Toxic Habits or Occupational Exposure following a Vegetarian Diet. Toxics.
- 27
Konstantin Salnikov, Anatoly Zhitkovich (2008). Genetic and Epigenetic Mechanisms in Metal Carcinogenesis and Cocarcinogenesis: Nickel, Arsenic, and Chromium. Chemical Research in Toxicology.
- 28
Maric D, Baralic K, Javorac D et al. (2023). Nickel as a potential disruptor of thyroid function: benchmark modelling of human data. Frontiers in Endocrinology.
- 29
Manal Abudawood, Hajera Tabassum, Atheer H. Alanazi et al. (2021). Antioxidant Status in Relation to Heavy Metals Induced Oxidative Stress in Patients with Polycystic Ovarian Syndrome (PCOS). Scientific Reports.
- 30
★Sweta Ghosh, Syam P. Nukavarpu, Venkatakrishna Rao Jala (2024). Effects of Heavy Metals on Gut Barrier Integrity and Gut Microbiota. Microbiota and Host.
- 31
★Bakulski KM, Seo YA, Hickman RC et al. (2020). Heavy Metals Exposure and Alzheimer's Disease and Related Dementias. Journal of Alzheimer's Disease.
- 32
Kamila Pokorska-Niewiada, Agnieszka Brodowska, Jacek Brodowski et al. (2022). Levels of Trace Elements in Erythrocytes as Endocrine Disruptors in Obese and Nonobese Women with Polycystic Ovary Syndrome. International Journal of Environmental Research and Public Health.
- 33
Di Gioacchino M, Gatta A, Della Valle L et al. (2018). Systemic Nickel Allergy Syndrome. Metal Allergy (book chapter).
- 34
★Robert J. Maier, Stéphane L. Benoit (2019). Role of Nickel in Microbial Pathogenesis. Inorganics.
- 35
Kathrin Schilling, Fiona Larner, Amina Saad et al. (2020). Urine metallomics signature as an indicator of pancreatic cancer. Metallomics.
- 36
Arshad M, Riaz N, Bashir R et al. (2023). Role of Some Heavy Metals in Rheumatoid Arthritis. Research Developments in Medicine and Medical Science Vol. 7.
- 37
Irfan S, Rani A, Riaz N et al. (2017). Comparative Evaluation of Heavy Metals in Patients with Rheumatoid Arthritis and Healthy Control in Pakistani Population. Iranian Journal of Public Health.
- 38
Fan W, Pi Z, Kong K et al. (2024). Analyzing the impact of heavy metal exposure on osteoarthritis and rheumatoid arthritis: an approach based on interpretable machine learning. Frontiers in Nutrition.
- 39
★Manish Mishra, Larry Nichols, Aditi A. Dave et al. (2022). Molecular Mechanisms of Cellular Injury and Role of Toxic Heavy Metals in Chronic Kidney Disease. International Journal of Molecular Sciences.
- 40
Mahendra Atlani, Ashok Kumar, Rajesh Ahirwar et al. (2024). Heavy Metal Association with Chronic Kidney Disease of Unknown Cause in Central India - Results from a Case-Control Study. BMC Nephrology.
- 41
★Ali AS, Nazar ME, Mustafa RM et al. (2024). Impact of heavy metals on breast cancer (Review). World Academy of Sciences Journal.
- 42
Smovrsnik T, Pinter B, Horvat M et al. (2025). Association of Trace Elements with Polycystic Ovary Syndrome in Women -- A Case-Control Study. Metabolites.
- 43
★Kirmizi DA, Baser E, Turksoy VA et al. (2020). Are Heavy Metal Exposure and Trace Element Levels Related to Metabolic and Endocrine Problems in Polycystic Ovary Syndrome?. Biological Trace Element Research.
- 44
Lombardi F, Fiasca F, Minelli M et al. (2020). The Effects of Low-Nickel Diet Combined with Oral Administration of Selected Probiotics on Patients with Systemic Nickel Allergy Syndrome (SNAS) and Gut Dysbiosis. Nutrients.
- 45
Schiavino D, Nucera E, Alonzi C et al. (2006). A Clinical Trial of Oral Hyposensitization in Systemic Allergy to Nickel. International Journal of Immunopathology and Pharmacology.
- 46
Lu H, Shi X, Han L et al. (2024). Association between nickel exposure and diabetes risk: an updated meta-analysis of observational studies. Frontiers in Public Health.
- 47
★Yucheng Liu, Xiaomin Luo, Yongde Peng et al. (2025). Cardio-Metabolic Effects of Nickel: A Narrative Review. Cardiovascular Toxicology.
- 48
★Karen Pendergrass (2026). Heavy Metals, Microbial Metallomics, and the US Obesity Epidemic: A Mechanistic Examination of a Population-Level Metabolic Disruption. Zenodo Preprint.
- 49
★Zhai Q, Wang G, Zhao J et al. (2016). Oral Administration of Probiotics Inhibits Absorption of the Heavy Metal Cadmium by Protecting the Intestinal Barrier. Appl Environ Microbiol.
- 50
Tarhonska K, Lesicka M, Janasik B et al. (2022). Cadmium and breast cancer - Current state and research gaps in the underlying mechanisms. Toxicology Letters.
- 51
★Kravchenko V, Zakharchenko T (2023). Kravchenko 2023 — Thyroid hormones and minerals in immunocorrection of disorders in autoimmune thyroid diseases. Frontiers in Endocrinology.
- 52
Luyun Fan, Junru Chen, Qi Zhang et al. (2025). Fecal microbiota transplantation for hypertension: an exploratory, multicenter, randomized, blinded, placebo-controlled trial. Microbiome.
- 53
Yeqing Zou, Anxing Ge, Brako Lydia et al. (2022). Gut mycobiome dysbiosis contributes to the development of hypertension and its response to immunoglobulin light chains. Frontiers in Immunology.
- 54
Lusi EA, Di Ciommo VM, Patrissi T et al. (2015). High Prevalence of Nickel Allergy in an Overweight Female Population: A Pilot Observational Analysis. PLoS ONE.
- 55
Hiremath KM, Dharambhat S, Mutalik N et al. (2021). Correlation of Serum Zinc Levels with Postpartum Depression - A Case-control Study in North Karnataka. Journal of Clinical and Diagnostic Research.
- 56
Yousaf A, Hagen R, Mitchell M et al. (2021). The effect of a low-nickel diet and nickel sensitization on gastroesophageal reflux disease: A pilot study. Indian Journal of Gastroenterology.
- 57
Rizzi A, Nucera E, Laterza L et al. (2017). Irritable Bowel Syndrome and Nickel Allergy: What Is the Role of the Low Nickel Diet?. Journal of Neurogastroenterology and Motility.
- 58
Borghini R, Porpora MG, Casale R et al. (2020). Irritable Bowel Syndrome-Like Disorders in Endometriosis: Prevalence of Nickel Sensitivity and Effects of a Low-Nickel Diet. An Open-Label Pilot Study. Nutrients.
- 59
Huang Y, Wei Y, Liang F et al. (2024). Exploring the link between dietary zinc intake and endometriosis risk: insights from a cross-sectional analysis of American women. BMC Public Health.
- 60
Karimi M, Rabiei R, Kazemi K et al. (2025). Karimi et al. 2025 — Effects of Probiotics and Synbiotics Oral Supplementation on Thyroid Function in Adults: A Grade-Assessed Systematic Review and Meta-Analysis. Thyroid Research.
- 61
Ng QX, Soh AYS, Venkatanarayanan N et al. (2019). A Systematic Review of the Effect of Probiotic Supplementation on Schizophrenia Symptoms. Neuropsychobiology.
- 62
Asher Dixon, Kai Robertson, Amanda Yung et al. (2020). Efficacy of Probiotics in Patients of Cardiovascular Disease Risk: A Systematic Review and Meta-Analysis. Current Hypertension Reports.
Article network
Mentioned here 13
Pages linking here 25
Connect the evidence
Publicly readable discussion by ORCID-authenticated researchers. Questions, interpretation, methods, corrections, and new evidence stay attached to this record.
No discussion yet. Start with a precise question or a source-backed observation.
Activity and accepted changes
Accepted researcher context, editorial status, public discussion, and upstream Git revisions are shown together. Pending, declined, and withdrawn proposals remain private.
- published revision
massive wiki expansion: 149 stubs fixed, 100+ new pages, Rule 15 scan, keystone papers
WikiBiome Deploy Bot · +159 −159
Inspect exact Git diff ↗ - published revision
nightly maintenance: 94 stub demotions, 181 source_count fixes, 22 auto-discovered stubs, 5 adversarial audits, 3 boundary fixes, 3 evidence-level corrections
WikiBiome Deploy Bot · +3 −91
Inspect exact Git diff ↗ - published revision
pre-overnight checkpoint 2026-04-18
WikiBiome Deploy Bot · +3 −3
Inspect exact Git diff ↗ - published revision
Deep content + citation pass: 10 entities enriched, 7 new sources, DOI integrity
WikiBiome Deploy Bot · +80 −80
Inspect exact Git diff ↗ - published revision
WikiBiome update — 2026-04-15 17:23
WikiBiome Deploy Bot · +62 −62
Inspect exact Git diff ↗ - published revision
WikiBiome v2 migration: signature pages + safety fixes + gap analysis
WikiBiome Deploy Bot · +295 −167
Inspect exact Git diff ↗ - published revision
WikiBiome update — integrity fixes, metallomic diet pages, cross-condition analyses
WikiBiome Deploy Bot · +3 −1
Inspect exact Git diff ↗ - published revision
WikiBiome v7 — interactive microbiome metallomics encyclopedia
Karen Pendergrass · +414 −0
Inspect exact Git diff ↗

